Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
222 participants
INTERVENTIONAL
2016-10-06
2017-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
However, recent publications have found that pro-vaccine messages can have paradoxical effects on vaccine intentions, therefore further studies on vaccine related public health communication is needed. The purpose of this study is to compare the effectiveness of pro-vaccine messages of local data, pro-vaccine messages of national data, and no educational message on patient's receipt of the influenza vaccine. These results will help to understand the relationship between patient education and the intent to vaccinate and receipt of the influenza vaccine as well as to optimize educational information given to patients regarding the influenza vaccine.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Influenza Vaccine Attitudes, Intent, and Receipt: Pediatric
NCT02907580
Pilot Text Message for Influenza Vaccination
NCT01761734
Impact of Patient Education on Influenza Vaccine Uptake Among Community-dwelling Chinese Elderly
NCT02741843
Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months
NCT00311428
Health Management Training to Enhance Influenza Vaccine Immunogenicity
NCT01256515
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Local educational
Adult patients in this arm receive educational information regarding influenza vaccination based on local data
Local educational information
Adult patients in this arm receive educational information regarding influenza vaccination based on local data
National educational
Adult patients in this arm receive educational information regarding influenza vaccination based on national data
National educational information
Adult patients in this arm receive educational information regarding influenza vaccination based on national data
Usual care
No educational information other than provided as usual care by health care providers
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Local educational information
Adult patients in this arm receive educational information regarding influenza vaccination based on local data
National educational information
Adult patients in this arm receive educational information regarding influenza vaccination based on national data
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Columbia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Melissa Stockwell
Associate Professor of Pediatrics and Population and Family Health
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Melissa Stockwell, MD MPH
Role: PRINCIPAL_INVESTIGATOR
Columbia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Columbia University Medical Center
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AAAR0289
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.